A frameshift mutation in BRCA1 leads to hereditary breast and ovarian cancer in one part of a family and to familial pancreatic cancer in another

Breast Cancer Res Treat. 2018 Jan;167(1):305-307. doi: 10.1007/s10549-017-4500-5. Epub 2017 Sep 12.

Laura Gieldon^{1

2

3

4}, Johannes Wagner^{5

6

7

8}, Andreas Rump^{5

6

7

8}

¹ Core Unit for Molecular Tumordiagnostics (CMTD), National Center for Tumor Diseases (NCT) partner site, Dresden, Germany. Laura.Gieldon@tu-dresden.de.
² German Cancer Research Center (DKFZ), Heidelberg, Germany. Laura.Gieldon@tu-dresden.de.
³ German Cancer Consortium (DKTK), Dresden, Germany. Laura.Gieldon@tu-dresden.de.
⁴ Institute for Clinical Genetics, Medical Faculty Carl Custav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany. Laura.Gieldon@tu-dresden.de.
⁵ Core Unit for Molecular Tumordiagnostics (CMTD), National Center for Tumor Diseases (NCT) partner site, Dresden, Germany.
⁶ German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁷ German Cancer Consortium (DKTK), Dresden, Germany.
⁸ Institute for Clinical Genetics, Medical Faculty Carl Custav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

No abstract available

Publication types